Nalan Akyürek

8PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Otorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 02, 2023
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer.

Görkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt

|Dec 23, 2022
Could PD-L1 positivity be associated with venous thrombosis in patients with non-small cell lung cancer?

Yasemin Söyler, Pınar Akın Kabalak, Suna Kavurgacı

|Sep 01, 2022
Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancer.

Orhun Akdoğan, Osman Sütcüoğlu, Betül Öğüt

|Jun 24, 2022
Histologic and Immunohistochemical Evaluation of Radiosurgery in Strabismus Surgery in a Rabbit Model.

Demet Yolcu, Ahmet M Hondur, Nalan Akyürek

Pageof 2